EVUMENA MUKORO: Open Payments
NPI 1356050462 · LAWRENCEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$113 in 7 payments from 5 companies in 2025. Trend: 2023 $322 · 2024 $145 · 2025 $113
Food & beverage: $113
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 1 | $29 |
| Calliditas Therapeutics US Inc. | 1 | $29 |
| ANI Pharmaceuticals, Inc. | 1 | $23 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Travere Therapeutics, Inc. | 3 | $10 |
Products named: Vanrafia, TARPEYO, PURIFIED CORTROPHIN GEL, FARXIGA.
Industry payments across GA — which companies pay providers there.
